Pimenta R, Costa-Rosa J, Cravo M, Rafael M, Moura C. Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma. SPDV [Internet]. 2021Apr.5 [cited 2024Nov.27];79(1):11-0. Available from: https://revista.spdv.com.pt/index.php/spdv/article/view/1288